Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · November 29, 2023

10-Day Vonoprazan–Amoxicillin Dual Therapy vs Standard Bismuth-Based Quadruple Therapy for the First-Line Eradication of H pylori Infection

The American Journal of Gastroenterology


Additional Info

Disclosure statements are available on the authors' profiles:

The American Journal of Gastroenterology
Ten-day vonoprazan-amoxicillin dual therapy versus standard fourteen-day Bismuth-based quadruple therapy for first-line Helicobacter pylori eradication: a multicenter randomized clinical trial
Am. J. Gastroenterol 2023 Nov 17;[EPub Ahead of Print], TL Yan, JH Wang, XJ He, YB Zhu, LJ Lu, YJ Wang, ZW Wang, JG Gao, CF Xu, H Ma, SM Luan, L Li, Y Chen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading